BioCentury | Sep 20, 2018
Distillery Therapeutics

Cancer

...compound in animal models of Gα-q-mutant uveal melanoma. TARGET/MARKER/PATHWAY: G protein q polypeptide (Gα-q; GNAQ); regulator of G-protein signaling...
...above email: kblumer@wustl.edu Claire Quang Washington University School of Medicine in St. Louis G protein q polypeptide (G-ALPHA-q) (GNAQ) Regulator of G-protein signaling...
BioCentury | Mar 1, 2018
Translation in Brief

New Therapeutic Targets and Biomarkers: February 2018

...could help treat the craniofacial disorder Treacher Collins syndrome. Stanford University Distillery Therapeutics Neurology Addiction Regulator of G-protein signaling...
BioCentury | Feb 14, 2018
Distillery Therapeutics

Neurology

...Next steps could include identifying and testing RGS20 inhibitors in models of morphine addiction. TARGET/MARKER/PATHWAY: Regulator of G-protein signaling...
...Medicine at Mount Sinai, New York, N.Y. email: venetia.zachariou@mssm.edu Allison Johnson Icahn School of Medicine at Mount Sinai Regulator of G-protein signaling...
BioCentury | Nov 2, 2016
Distillery Techniques

Biomarkers

...high mRNA expression of genes not previously reported to be expressed in the pancreas, including regulator of G-protein signaling...
...doi:10.1016/j.cmet.2016.08.020 CONTACT: Rickard Sandberg, Karolinska Institute, Stockholm, Sweden email: rickard.sandberg@ki.se Esme Gaisford Muscarinic acetylcholine receptor M3 (CHRM3) (HM3) Regulator of G-protein signaling...
BioCentury | May 23, 2013
Distillery Therapeutics

Indication: Neurology

...Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Depression; pain Regulator of G-protein signaling 4 (RGS4) Mouse...
BioCentury | Mar 14, 2013
Distillery Therapeutics

Indication: Cardiovascular disease

...Publication and contact information Cardiovascular disease Hypertrophy Endothelial cell nitric oxide synthase 3 (NOS3; eNOS); regulator of G-protein signaling...
BioCentury | Mar 8, 2012
Distillery Therapeutics

Indication: Neurology

...Publication and contact information Neurology Seizures Protein phosphatase 1 regulatory inhibitor subunit 9A (PPP1R9A; neurabin-1); regulator of G-protein signaling...
BioCentury | Mar 8, 2012
Distillery Therapeutics

Indication: Autoimmune Disease

...affiliation as above e-mail: jjiang3@emory.edu Seizures Protein phosphatase 1 regulatory inhibitor subunit 9A (PPP1R9A; neurabin-1); regulator of G-protein signaling...
BioCentury | Feb 9, 2012
Distillery Therapeutics

Indication: Neurology

...Indication Target/marker/pathway Summary Licensing status Publication and contact information Neurology Parkinson's disease (PD) Regulator of G-protein signaling 4 (RGS4...
BioCentury | Aug 5, 2010
Distillery Therapeutics

Indication: Cardiovascular disease

...Indication Target/marker/pathway Summary Licensing status Publication and contact information Cardiovascular disease Heart failure Regulator of G-protein signaling 5 (RGS5...
Items per page:
1 - 10 of 15